About
ART BioScience specializes in the use of novel messenger RNA technologies for the development of therapeutics that may potentially change the course of Duchenne Muscular Dystrophy.
The company’s initial work began with lipids licensed from the laboratory of Professor Dan Peer. ART BioScience has optimized these lipids for effective muscle delivery based on a proprietary LNP-based formulation. The delivery system enables the efficient transfer of mRNA to the muscles via systemic administration. The technology reflects years of work scanning numerous lipids and optimizing the formulations for delivery.
ART BioScience was founded by Mr. Oren Ozeri and Mr. Alon Hazan, fathers of two children diagnosed with Duchenne Muscular Dystrophy.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is ART BioScience's primary focus?
- ART BioScience specializes in developing genetic therapies for Duchenne Muscular Dystrophy using novel messenger RNA technologies.
- When was ART BioScience founded?
- ART BioScience was founded in July 2015.
- Who founded ART BioScience and what was their motivation?
- ART BioScience was founded by Mr. Oren Ozeri and Mr. Alon Hazan, both fathers of children diagnosed with Duchenne Muscular Dystrophy.
- What is the core technology behind ART BioScience's therapeutics?
- ART BioScience's core technology involves optimizing proprietary LNP-based formulations for effective muscle delivery of mRNA via systemic administration, based on lipids licensed from Professor Dan Peer's laboratory.
- What is ART BioScience's current funding stage?
- According to startupim data, ART BioScience is currently in the Pre-Funding stage.
- How many employees does ART BioScience have?
- ART BioScience has 7 employees.
- Where is ART BioScience headquartered?
- ART BioScience is headquartered in Rehovot, Israel.
- What is the primary sector of ART BioScience?
- ART BioScience's primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.